XML 24 R14.htm IDEA: XBRL DOCUMENT v3.19.2
Goodwill and Intangible Assets, Net
6 Months Ended
Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net

8. Goodwill and Intangible Assets, Net

 

At June 30, 2019 and December 31, 2018, goodwill and intangible assets, net consisted of the following (in thousands):

 

  

June 30,

2019

  

December 31,

2018

 
   (unaudited)     
Goodwill(1)  $12,977   $- 
           
Intangible assets:          
Acquired IPR&D - OPC1 (from the Asterias Merger) (2)  $31,700   $- 
Acquired IPR&D - VAC2 (from the Asterias Merger) (2)   14,840    - 
Intangible assets subject to amortization:          
Acquired patents   19,010    19,010 
Acquired royalty contracts (2)   650      
Other   10    10 
Total intangible assets   66,210    19,020 
Accumulated amortization   (16,889)   (15,895)
Intangible assets, net  $49,321   $3,125 

 

(1) Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired and liabilities assumed in the Asterias Merger (see Note 3).
   
(2) See Note 3 for information on the Asterias Merger which was consummated on March 8, 2019.

 

BioTime recognized in research and development expenses $475,000 and $581,000 of amortization expense in the three months ended June 30, 2019 and 2018, and $949,000 and $1.2 million in the six months ended June 30, 2019 and 2018, respectively.